BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16989720)

  • 1. Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis.
    Recillas-Targa F; De La Rosa-Velázquez IA; Soto-Reyes E; Benítez-Bribiesca L
    J Cell Mol Med; 2006; 10(3):554-68. PubMed ID: 16989720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.
    De La Rosa-Velázquez IA; Rincón-Arano H; Benítez-Bribiesca L; Recillas-Targa F
    Cancer Res; 2007 Mar; 67(6):2577-85. PubMed ID: 17363576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
    Parfett CL; Desaulniers D
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of CCCTC-binding factor in epigenetic regulation of cancer.
    Bose S; Saha S; Goswami H; Shanmugam G; Sarkar K
    Mol Biol Rep; 2023 Dec; 50(12):10383-10398. PubMed ID: 37840067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines.
    Soto-Reyes E; Recillas-Targa F
    Oncogene; 2010 Apr; 29(15):2217-27. PubMed ID: 20101205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary.
    Witcher M; Emerson BM
    Mol Cell; 2009 May; 34(3):271-84. PubMed ID: 19450526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and epigenetics of the multifunctional protein CTCF.
    Filippova GN
    Curr Top Dev Biol; 2008; 80():337-60. PubMed ID: 17950379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.
    Batlle-López A; Cortiguera MG; Rosa-Garrido M; Blanco R; del Cerro E; Torrano V; Wagner SD; Delgado MD
    Oncogene; 2015 Jan; 34(2):246-56. PubMed ID: 24362533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of the XAF1 gene is mediated by the loss of CTCF binding.
    Victoria-Acosta G; Vazquez-Santillan K; Jimenez-Hernandez L; Muñoz-Galindo L; Maldonado V; Martinez-Ruiz GU; Melendez-Zajgla J
    Sci Rep; 2015 Oct; 5():14838. PubMed ID: 26443201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression.
    Kang JY; Song SH; Yun J; Jeon MS; Kim HP; Han SW; Kim TY
    Oncogene; 2015 Nov; 34(45):5677-84. PubMed ID: 25703332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.
    Ayala-Ortega E; Arzate-Mejía R; Pérez-Molina R; González-Buendía E; Meier K; Guerrero G; Recillas-Targa F
    BMC Cancer; 2016 Mar; 16():226. PubMed ID: 26983574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTCF haploinsufficiency destabilizes DNA methylation and predisposes to cancer.
    Kemp CJ; Moore JM; Moser R; Bernard B; Teater M; Smith LE; Rabaia NA; Gurley KE; Guinney J; Busch SE; Shaknovich R; Lobanenkov VV; Liggitt D; Shmulevich I; Melnick A; Filippova GN
    Cell Rep; 2014 May; 7(4):1020-9. PubMed ID: 24794443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic dysregulation by nickel through repressive chromatin domain disruption.
    Jose CC; Xu B; Jagannathan L; Trac C; Mallela RK; Hattori T; Lai D; Koide S; Schones DE; Cuddapah S
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):14631-6. PubMed ID: 25246589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional and epigenetic regulation of the p53 tumor suppressor gene.
    Saldaña-Meyer R; Recillas-Targa F
    Epigenetics; 2011 Sep; 6(9):1068-77. PubMed ID: 21814038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
    Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
    Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention.
    Atkinson SP; Keith WN
    Expert Rev Mol Med; 2007 Mar; 9(7):1-26. PubMed ID: 17352843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTCF demarcates chicken embryonic α-globin gene autonomous silencing and contributes to adult stage-specific gene expression.
    Valdes-Quezada C; Arriaga-Canon C; Fonseca-Guzmán Y; Guerrero G; Recillas-Targa F
    Epigenetics; 2013 Aug; 8(8):827-38. PubMed ID: 23880533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus Rta-Mediated Accumulation of DNA Methylation Interferes with CTCF Binding in both Host and Viral Genomes.
    Chen YJ; Chen YL; Chang Y; Wu CC; Ko YC; Tsao SW; Chen JY; Lin SF
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.
    Méndez-Catalá CF; Gretton S; Vostrov A; Pugacheva E; Farrar D; Ito Y; Docquier F; Kita GX; Murrell A; Lobanenkov V; Klenova E
    Neoplasia; 2013 Aug; 15(8):898-912. PubMed ID: 23908591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide targeting of the epigenetic regulatory protein CTCF to gene promoters by the transcription factor TFII-I.
    Peña-Hernández R; Marques M; Hilmi K; Zhao T; Saad A; Alaoui-Jamali MA; del Rincon SV; Ashworth T; Roy AL; Emerson BM; Witcher M
    Proc Natl Acad Sci U S A; 2015 Feb; 112(7):E677-86. PubMed ID: 25646466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.